EU Oral Drugs for Rheumatoid Arthritis Treatment Market


  • Type: Common Disease Area
  • Published : March 2021
  • Region: Europe
  • Country: Other
  • Report ID : 570

  • Format: PPT, PDF

EU Oral Drugs For Rheumatoid Arthritis Treatment – Growth, Trends, Segmented by Drug Class (Pharmaceutical, and Biopharmaceutical) and by Dosage Form (Tablet, Capsule, and Liquid) and Forecasts (2019-2028)


Report Overview

The oral drugs for the rheumatoid arthritis market in the EU are projected to reach USD XX billion by 2028 from USD XX billion in 2019, at a CAGR of 3.11% from 2019 to 2028

Rheumatoid Arthritis usually affects the geriatric population, and the prevalence is seen higher in females as compared to males. There are also several therapeutics and medications that have been developed in recent years, to treat the symptoms of rheumatoid arthritis. Rheumatoid Arthritis treatment is generally lifelong and can require medication changes. No single DMARD(Disease Modifying Anti-Rheumatoid Drugs) is superior as an initial treatment; however, methotrexate is commonly used. In the EU, the increasing number of effective drugs and modes of action (MOAs) has improved the likelihood of reaching the treatment target for individuals with RA, but high drug costs still limit widespread use and thus contribute to inequity of access to best care across various regions in EU

Market Growth Drivers

The key factors propelling the growth of the oral drug for the rheumatoid arthritis treatment market are the new developments in the field of new biosimilars. The rising prevalence of Rheumatoid Arthritis and an increase in the acceptance of biopharmaceuticals will fuel the growth of this market

1. EU Oral Drugs for Rheumatoid Arthritis Treatment Market Overview………..
A. Market Size
2. Market Growth Drivers……………………………………………………….……………………………….
A. Rising Prevalence of Rheumatoid Arthritis in EU
B. Growing developments in the Biosimilars and rising acceptance of biopharmaceuticals
3. EU Oral Drugs for Rheumatoid ArthritisMarket Segmentation……………….
A. By Drug Class
I. Pharmaceutical
II. Biopharmaceutical
B. By Dosage Form
I. Tablet
II. Capsule
III. Liquid
4. EU Oral Drugs for Rheumatoid Arthritis Treatment Market Share……………..
A. Market Analysis, Insights and Forecast to 2028 by Revenue
5. Competitive Landscape…………………………………………………………………………….………..
A. Major Players
B. Products in Pipeline
6. Key Company Profiles……………………………………………………….……………………………….
A. Eli Lily Company overview, Product & Services, Strategies & Financials
B. AbbeVie Inc. overview, Product & Services, Strategies & Financials
C. Bristol-Myers Squibb Company Profile, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape…………………………………….…
A. Policy changes and Reimbursement scenario
8. Potential Growth Opportunities………………………………………………..…………
A. Advancements in drug development
9. Factors Driving Future Growth…………………………………………………………..
A. Key Industry Trends and Recent Developments in EU Oral Drugs for Rheumatoid Arthritis Treatment Market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Drug Class:

The Pharmaceutical segment consists of NSAIDs (Nonsteroidal Anti-Inflammatory Drugs), Corticosteroids, DMARDs (Disease-modifying anti-rheumatic drugs), and Analgesics. NSAIDs are being widely utilized for the symptomatic treatment of rheumatic disorders. NSAIDs, by Drug Class, is Expected to be the Largest Segment Over the Forecast Period. With the growing number of arthritis cases, the use of NSAIDs and their production is expected to observe healthy demand and supply throughout the forecast period. Disease-modifying anti-rheumatic drugs (DMARDs) are also considered as the gold standard for the treatment of moderate to severe Rheumatoid Arthritis. DMARDs are thought to work by suppressing an overactive immune system. Corticosteroids are used for Rheumatoid Arthritis because of their anti-inflammatory and immunosuppressive effects. They are commonly used as an adjunct to DMARDs, particularly early in treatment

The Biopharmaceuticals are further segregated into Biologics. Unlike conventional DMARDs, biologic drugs are more efficient in the management of Rheumatoid Arthritis. However, the only available oral biologic drug is the JAK 2 inhibitor

By Dosage Form:

The Oral Drug for Rheumatoid Arthritis Treatment Market is further segmented on the basis of Dosage forms into Capsule, tablet, and Liquid. For example, Plaquenil and oral DMARDs are administered in the form of a tablet whereas, a JAK2 inhibitor is taken in the form of a capsule

Key players

A majority of Rheumatoid Arthritis drug products are being manufactured by key players. The market leaders in this industry have established their position in the market. Some of them are, AbbeVie Inc., Amgen Inc, Bayer AG, Eli Lily Co, Bristol-Myers Squibb Company. Eli Lilly and Company and Incyte Corporation announced that the European Commission has granted marketing authorization for Olumiant (baricitinib) 4 mg and 2 mg film-coated tablets in the EU for the treatment of moderate-to-severe active rheumatoid arthritis (RA) in adult patients. In 2019, AbbVie announced that the European Commission (EC) has approved RINVOQ (upadacitinib) for the treatment of adult patients with moderate to severe active rheumatoid arthritis who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (DMARDs)

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements